Clinical Trial: Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers

U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07727629) titled 'Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers' on June 18.

Brief Summary: A randomized, open-label, multiple-dose, crossover phase 1 clinical trial to compare and evaluate the safety, pharmacokinetics and pharmacodynamics characteristics after oral administration of UI059 and UIC202201 in healthy adult volunteers

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Gastro Esophageal Reflux Disorder

Intervention: DRUG: UI059

take UI059 once a day for 7 days

DRUG: UIC202201

take UIC202201 once a day for 7 days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Korea United Pharm. Inc....